ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Genprex Inc

Genprex Inc (GNPX)

0.505
0.005
( 1.00% )
Actualizado: 11:05:43

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
0.505
Postura de Compra
0.505
Postura de Venta
0.5098
Volume Operado de la Acción
102,705
0.5001 Rango del Día 0.529
0.2806 Rango de 52 semanas 6.49
Capitalización de Mercado [m]
Precio Anterior
0.50
Precio de Apertura
0.51
Última hora de negociación
11:14:50
Volumen financiero
US$ 52,416
Precio Promedio Ponderado
0.510355
Volumen promedio (3 m)
569,609
Acciones en circulación
8,508,068
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.14
Beneficio por acción (BPA)
-3.63
turnover
-
Beneficio neto
-30.86M

Acerca de Genprex Inc

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who cur... Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex's oncology program utilizes its systemic, non-viral Oncoprex® Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The resultant product is administered intravenously, where it is taken up by tumor cells that then express tumor suppressor proteins that were deficient in the tumor. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Genprex Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GNPX. The last closing price for Genprex was US$0.50. Over the last year, Genprex shares have traded in a share price range of US$ 0.2806 to US$ 6.49.

Genprex currently has 8,508,068 shares in issue. The market capitalisation of Genprex is US$4.25 million. Genprex has a price to earnings ratio (PE ratio) of -0.14.

GNPX Últimas noticias

Genprex Announces First Patient Dosed in Phase 2 Expansion Portion of Acclaim-3 Clinical Study of Reqorsa® Gene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer

Genprex Announces First Patient Dosed in Phase 2 Expansion Portion of Acclaim-3 Clinical Study of Reqorsa® Gene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer PR...

Genprex to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

Genprex to Participate at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire AUSTIN, Texas, Jan. 6, 2025 AUSTIN, Texas, Jan. 6, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the...

Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer

Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.0956-15.91741591740.60060.650.49532450070.55862504CS
4-0.285-36.07594936710.790.790.49532371890.65613946CS
12-1.195-70.29411764711.71.80.49535696091.01524008CS
26-0.965-65.64625850341.473.9610.280649989642.14761942CS
52-5.635-91.77524429976.146.490.280625394842.16428597CS
156-88.295-99.431306306388.8106.80.2806109972611.16157753CS
260-55.495-99.098214285756308.80.2806160095289.11246193CS

GNPX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Genprex?
El precio actual de las acciones de Genprex es US$ 0.505
¿Cuántas acciones de Genprex están en circulación?
Genprex tiene 8,508,068 acciones en circulación
¿Cuál es la capitalización de mercado de Genprex?
La capitalización de mercado de Genprex es USD 4.25M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Genprex?
Genprex ha negociado en un rango de US$ 0.2806 a US$ 6.49 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Genprex?
El ratio precio/beneficio de Genprex es -0.14
¿Cuál es la moneda de reporte de Genprex?
Genprex presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Genprex?
El último beneficio anual de Genprex es USD -30.86M
¿Cuál es la dirección registrada de Genprex?
La dirección registrada de Genprex es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Genprex?
La dirección del sitio web de Genprex es www.genprex.com
¿En qué sector industrial opera Genprex?
Genprex opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
QNTMQuantum Biopharma Ltd
US$ 17.36
(102.33%)
28.72M
LTRYLottery com Inc
US$ 0.9455
(93.00%)
155.35M
APPSDigital Turbine Inc
US$ 4.515
(77.76%)
85.8M
LIPOLipella Pharmaceuticals Inc
US$ 4.41
(70.93%)
73.7M
INVZWInnoviz Technologies Ltd
US$ 0.15
(65.56%)
145.53k
RETOReTo Eco Solutions Inc
US$ 0.4947
(-38.16%)
614.01k
SDASunCar Technology Group Inc
US$ 5.36
(-36.49%)
2.83M
AVGRAvinger Inc
US$ 0.38395
(-31.43%)
1.05M
SRTSSensus Healthcare Inc
US$ 6.1999
(-31.04%)
1.81M
CRMLCritical Metals Corporation
US$ 6.19
(-29.01%)
724.64k
MGOLMGO Global Inc
US$ 0.1897
(36.47%)
257.43M
LTRYLottery com Inc
US$ 0.9455
(93.00%)
155.35M
NVDANVIDIA Corporation
US$ 127.34
(2.01%)
128.32M
CYNCYNGN Inc
US$ 0.0784
(-4.39%)
102.29M
RIMEAlgorhythm Holdings Inc
US$ 0.02175
(4.07%)
91.48M

GNPX Discussion

Ver más
laraz5 laraz5 1 semana hace
What a horrible trade? You've done nothing but post buys lower and lower?

Feeding right into the dilution?

While claiming some false DD led you to Invest?

How could anyone be this wrong every time?

IMO
👍️0
laraz5 laraz5 2 semanas hace
Seems they haven't reported the O/S since November?

Any guesses why?

I have an idea?

Theft?

IMO
👍️0
laraz5 laraz5 2 semanas hace
These con artist promoters are now updating there calls lower lower and lower?

Always adding?

PPS always dropping?

They mist be shorting?

GNPX could be a pyramid scheme using the sympathetic nature of Cancer as a way to dilute and steal funds from innocent investors?

IMO
👍️0
laraz5 laraz5 2 semanas hace
You are down already? You've called this from 2.00 to .71 adding all the way?

You might want to DD because at this rate it appears your are just losing money and giving out bad advice?

IMO
👍️0
georgie18 georgie18 2 semanas hace
GNPX...76...Added on News...🥳...https://www.prnewswire.com/news-releases/genprex-announces-first-patient-dosed-in-phase-2-expansion-portion-of-acclaim-3-clinical-study-of-reqorsa-gene-therapy-in-combination-with-tecentriq-to-treat-small-cell-lung-cancer-302358445.html

georgie18

Member Level
Re: georgie18 post# 4032

Monday, December 16, 2024 9:31:30 AM

Post#
4034
of 4037
GNPX...$1.26...🥳...AUSTIN, Texas , Dec. 16, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it has completed the Phase 1 dose escalation portion of the Acclaim-3 clinical trial of Reqorsa® Gene Therapy (quaratusugene ozeplasmid) in combination with Tecentriq® (atezolizumab) as maintenance therapy to treat patients with extensive stage small cell lung cancer (ES-SCLC). In addition, the Safety Review Committee (SRC) has approved the opening of the Phase 2 expansion portion of the trial.

The combination of REQORSA and atezolizumab previously received U.S. Food and Drug Administration's (FDA) Fast Track Designation for the treatment of the Acclaim-3 patient population, and the FDA has also granted Orphan Drug Designation to REQORSA for the treatment of SCLC.

Based on full safety data, which showed no dose limiting toxicities (DLTs), the SRC determined that the Recommended Phase 2 Dose (RP2D) of REQORSA will be 0.12 mg/kg. This was the highest dose level delivered in the Phase 1 portion of the trial. The SRC also recommended the trial advance to the Phase 2 expansion portion of the study, which the Company has now opened for enrollment.
👍️0
laraz5 laraz5 1 mes hace
Good Job fraud promoters coming in and plastering crap about this pyramid scheme at 1.5 now almost down 50% in just about a month?

Well done?

How many got diluted?

Tough to say since GNPX doesn't report?

Loophole?

Nothing like a scam off the backs of Cancer?

Ryan Confer might be knowing frauding the public off the idea of Cancer?

What kind of low life does such a thing?

Rodney Varner the man with many names and many years of stick manipulation does suddenly and Ryan Confer takes over?

How deep does the pyramid scheme of GNPX go?

IMO
👍️0
laraz5 laraz5 2 meses hace
Unlimited theft in the name of Cancer research?

It's one thing to create an imaginary product and sell shares of its ideas?

But to sell shares based on the idea of combating cancer takes some sick people?

IMO
👍️0
georgie18 georgie18 2 meses hace
GNPX...$1.26...🥳...AUSTIN, Texas , Dec. 16, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it has completed the Phase 1 dose escalation portion of the Acclaim-3 clinical trial of Reqorsa® Gene Therapy (quaratusugene ozeplasmid) in combination with Tecentriq® (atezolizumab) as maintenance therapy to treat patients with extensive stage small cell lung cancer (ES-SCLC). In addition, the Safety Review Committee (SRC) has approved the opening of the Phase 2 expansion portion of the trial.

The combination of REQORSA and atezolizumab previously received U.S. Food and Drug Administration's (FDA) Fast Track Designation for the treatment of the Acclaim-3 patient population, and the FDA has also granted Orphan Drug Designation to REQORSA for the treatment of SCLC.

Based on full safety data, which showed no dose limiting toxicities (DLTs), the SRC determined that the Recommended Phase 2 Dose (RP2D) of REQORSA will be 0.12 mg/kg. This was the highest dose level delivered in the Phase 1 portion of the trial. The SRC also recommended the trial advance to the Phase 2 expansion portion of the study, which the Company has now opened for enrollment.
👍️0
BurgerKing82 BurgerKing82 2 meses hace
Looking good...P.T?
👍️0
georgie18 georgie18 2 meses hace
GNPX...$1.12...🥳...Psar flipped Bullish...Bollies are starting to Squeeze here...Been averaging down and Accumulating...
👍️0
laraz5 laraz5 2 meses hace
New O/S 8,508,068 six million shares diluted since last report month back?

6 million shares while the con artist 3rd party promoters came in and played pump n dump with the shell?

Don't anyone worry the O/S is going much higher and the PPS is going much lower?

Does Ryan M Confer understand about pyramid schemes?

I believe Rodney Varner is going to have some explaining to do where he is headed?

If Ryan M Confer turned out to take the torch from Varner by getting cancer products tweaking them and diluting shares while creating a false hope then this won't be his last time getting involved in possible pyramid schemes?

IMO

👍️0
laraz5 laraz5 3 meses hace
You think you know the current O/S or will you guess at that as well?

GNPX is a pyramid scheme?

IMO
👍️0
Savannah-Marc Savannah-Marc 3 meses hace
I think it will run but "when" is the question, depends on if we get a favorable settlement or judgement from the court case. I think the appellant is running the clock to come up with a decent enough settlement agreement because in my opinion, a court decision would ruin them.
👍️0
J2003 J2003 3 meses hace
More news tomorrow!
👍️0
laraz5 laraz5 3 meses hace
What's the current O/S? Since shamelessly promoting a pyramid scheme tanking daily off news at least tell shareholders what's the current O/S is?

Unless you simply don't know it?

Stop promoting scams?

IMO
👍️0
georgie18 georgie18 3 meses hace
GNPX...$1.27...NEWS...🥳...https://www.prnewswire.com/news-releases/genprex-signs-exclusive-license-to-additional-gene-therapy-technologies-with-the-university-of-michigan-for-the-treatment-of-lung-cancer-302311506.html
👍️0
laraz5 laraz5 3 meses hace
Scoop like cat litter? Does Ryan know where this possible pyramid scheme was originated and how this ends for him?

Does Ryan Confer just get to walk away after a possible billions are diluted and GNPX tumbles into BK?

Michael T Redmands stank is still riddled in this mess?

IMO
👍️0
CelestialEnchanter69 CelestialEnchanter69 3 meses hace
Get the Inside Scoop on Genprex
Want to know more about Genprex (NASDAQ: GNPX)? Watch the exclusive interview with CEO Ryan Confer. He discusses the company's latest developments in diabetes and oncology.
Join the Future 1% community for free to access this insightful interview and other exclusive content.

https://marathonmoneyplus.com/2024/10/28/marathon-money-ft-ceo-mr-ryan-m-confer-m-s-genprex-gnpx/

#MarathonMoney #Future1% #GNXP #biotech #investing
👍️0
laraz5 laraz5 3 meses hace
GNPX is failing to disclose the O/S?

Is it still 2.5 million?

Or 50,000?

They seem to have neglected any reporting since August?

Seems like a Michael Redmond type of pyramid scheme?

Oh don't worry they fired him after he drew them a blueprint?


Bankruptcy soon but no jail time they all get away with it?


IMO
👍️0
laraz5 laraz5 3 meses hace
2.09? Hahaha loser 3rd party promoters trying to sell crap? It reduced tumors?

Does anyone believe such garbage?

These animals come around screaming about falsehoods while they sell?

GNPX could very well be a pyramid scheme selling millions and millions of shares while low intelligence 3rd party cons come in and drop lies?

Already down another 10%?

Keep them newsletters coming con artists?

Don't believe me then tell me what the O/S is today?

IMO
👍️0
tw0122 tw0122 3 meses hace
Reduced tumors in mice, regained compliance,
Low floater $2.09.
GNS nice flip last night 
👍️0
Invest-in-America Invest-in-America 3 meses hace
GNPX: Too bad TRUMP got in --- if he hadn't, all that Bitcoin crap would NEVER have gone anywhere and, as such, we would have a lot more SUBSTANTIVE stocks to think about.

Bitcoin Definition: "A solution to a problem that NEVER existed in the first place."
👍️0
tw0122 tw0122 3 meses hace
Heads-up last night but so many up today)2.07 + 50%
👍️0
TrendTrade2016 TrendTrade2016 3 meses hace
GNPX ON THE MOVE
👍️0
georgie18 georgie18 3 meses hace
GNPX...$1.82...Bouncing off the 100ma...🥳

georgie18

Member Level
Re: georgie18 post# 4009

Thursday, November 07, 2024 9:55:03 AM

Post#
4010
of 4016
GNPX...$1.77...🥳

georgie18

Member Level
Re: georgie18 post# 663002

Thursday, November 07, 2024 8:44:53 AM

Post#
663957
of 663985
GNPX...$1.60... https://schrts.co/nfchkggS ...🥳...Bullish 3 Gap Downs Reversal Pattern...Lets see if the pattern sticks...

GNPX...$2.79s clearing here...🥳First alerted at .37 and ran to $4 range...

georgie18

Member Level
Re: georgie18 post# 662935

Monday, October 28, 2024 12:48:49 PM

Post#
662948
of 663001
GNPX...$2.58s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 3991

Monday, October 28, 2024 11:52:45 AM

Post#
3998
of 3998
GNPX...$2.14...Trying to Reverse here...🥳Following the gap fill...Holding higher and averaging down...
👍️0
glenn1919 glenn1919 3 meses hace
GNPX..........................https://stockcharts.com/h-sc/ui?s=GNPX&p=W&b=5&g=0&id=p86431144783
👍️0
laraz5 laraz5 3 meses hace
Now down 1.50 since this epic horror call?

Where do they find them?

Shameful?

Shame?

Shame?


IMO
👍️0
laraz5 laraz5 3 meses hace
Complete and Total horseshit?

Your continues pre pump and post pump R/S is nonsense?

Shame on you?

IMO
👍️0
georgie18 georgie18 3 meses hace
Are you a moron or do you just play one on Ihub...I alerted GNPX at .37 and it ran to $4 range...you failed to mention that...oops...I don't pump and I do not have and subscribers...🥳

Don't post shit you have no idea about...Have Great Day...
👍️0
laraz5 laraz5 3 meses hace
Now down 50% since you pumped 2.70?

What type of promotion is GNPX?

This is the worst collapse since the hindenburg disaster?

Can any of your subscribers get a refund is they purchased?

IMO
👍️0
georgie18 georgie18 3 meses hace
Have a Great Weekend Y'all...🥳
👍️0
georgie18 georgie18 3 meses hace
GNPX...$1.77...🥳

georgie18

Member Level
Re: georgie18 post# 663002

Thursday, November 07, 2024 8:44:53 AM

Post#
663957
of 663985
GNPX...$1.60... https://schrts.co/nfchkggS ...🥳...Bullish 3 Gap Downs Reversal Pattern...Lets see if the pattern sticks...

GNPX...$2.79s clearing here...🥳First alerted at .37 and ran to $4 range...

georgie18

Member Level
Re: georgie18 post# 662935

Monday, October 28, 2024 12:48:49 PM

Post#
662948
of 663001
GNPX...$2.58s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 3991

Monday, October 28, 2024 11:52:45 AM

Post#
3998
of 3998
GNPX...$2.14...Trying to Reverse here...🥳Following the gap fill...Holding higher and averaging down...
👍️0
georgie18 georgie18 3 meses hace
GNPX...$1.60... https://schrts.co/nfchkggS ...🥳...Bullish 3 Gap Downs Reversal Pattern...Lets see if the pattern sticks...

GNPX...$2.79s clearing here...🥳First alerted at .37 and ran to $4 range...

georgie18

Member Level
Re: georgie18 post# 662935

Monday, October 28, 2024 12:48:49 PM

Post#
662948
of 663001
GNPX...$2.58s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 3991

Monday, October 28, 2024 11:52:45 AM

Post#
3998
of 3998
GNPX...$2.14...Trying to Reverse here...🥳Following the gap fill...Holding higher and averaging down...
👍️0
laraz5 laraz5 3 meses hace
Hey GNPX is the O/S still 2.5 million? It's been months since you updated?

Are you stealing or not?

Prove me wrong about a pyramid scam being produced off a previous failure?

IMO
👍️0
laraz5 laraz5 3 meses hace
They inflated the PPS to sell more shares?

Toxic finance pyramid scheme based of hypethical nonsense?


IMO
👍️0
laraz5 laraz5 3 meses hace
Diluted pyramid scam O/S continues its rise and the news keeps pouring out?

Pump and dump?

Mike Redmond originated con job?


IMO
👍️0
SolarRevolution SolarRevolution 3 meses hace
Tumour remission documented by three university's and patents applied for!!!
👍️0
SolarRevolution SolarRevolution 3 meses hace
Good support after hours lung cancer tumours remission data and two patents applied for!
👍️0
georgie18 georgie18 3 meses hace
GNPX...$2.79s clearing here...🥳First alerted at .37 and ran to $4 range...

georgie18

Member Level
Re: georgie18 post# 662935

Monday, October 28, 2024 12:48:49 PM

Post#
662948
of 663001
GNPX...$2.58s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 3991

Monday, October 28, 2024 11:52:45 AM

Post#
3998
of 3998
GNPX...$2.14...Trying to Reverse here...🥳Following the gap fill...Holding higher and averaging down...
👍 1
SolarRevolution SolarRevolution 3 meses hace
Great day glad I held! 
👍️0
glenn1919 glenn1919 3 meses hace
GNPX......................https://stockcharts.com/h-sc/ui?s=GNPX&p=W&b=5&g=0&id=p86431144783
👍 1
georgie18 georgie18 3 meses hace
GNPX...$2.58s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 3991

Monday, October 28, 2024 11:52:45 AM

Post#
3998
of 3998
GNPX...$2.14...Trying to Reverse here...🥳Following the gap fill...Holding higher and averaging down...
👍 1
georgie18 georgie18 3 meses hace
GNPX...$2.14...Trying to Reverse here...🥳Following the gap fill...Holding higher and averaging down...
👍️0
SolarRevolution SolarRevolution 3 meses hace
Ready to get back to the action, lung cancer tumour remission data will not take long to get out to major partners, fast track fda approval should be the catalyst for quick buyout and bidding war over shares of Genprex.

Lung cancer tumours in remission !!  Very good news all through October 2024, November will be good for shareholders! 
👍️0
georgie18 georgie18 3 meses hace
Have a Great Weekend Y'all...🥳
👍 1
SolarRevolution SolarRevolution 3 meses hace
Looks life some life back in this, word is very impressive updates after the conference concludes today in Spain , lung cancer treatment with impressive results 30% remission of tumours ! 
👍️0
The_BORG The_BORG 3 meses hace
Where are your great 14$ ???

lol !!!

Down 20% every day, falling like a stone towards 0
But what else can you read here.... Only dreamers and hopefuls who don't understand that they are constantly being bloodily screwed by big short addresses....
👍️0
SolarRevolution SolarRevolution 3 meses hace
Word is more results to be announced after the October 23-25 conference happening now in Spain 🇪🇸 
👍️0
The_BORG The_BORG 3 meses hace
blah blah blah

just one bloody gambler and soldier of fortune....
If it goes well, they brag again, if it goes down the drain you don't hear a word more....
as always.....
👍️0
georgie18 georgie18 3 meses hace
GNPX...$2.27...🥳Following the gap fill...

georgie18

Member Level
Re: georgie18 post# 3986

Thursday, October 24, 2024 10:09:46 AM

Post#
3989
of 3990
GNPX...$2.17...Open Gap filled...🥳

georgie18

Member Level
Re: georgie18 post# 662307

Wednesday, October 23, 2024 10:05:02 AM

Post#
662384
of 662554
GNPX...$2.90...Holding and bidding the $2.20 range open gap...🥳
👍️0